Literature DB >> 1741287

Effective incorporation of 2'-O-methyl-oligoribonucleotides into liposomes and enhanced cell association through modification with thiocholesterol.

B Oberhauser1, E Wagner.   

Abstract

Cholesterol was linked to 2'-O-methyl-oligoribonucleotides (2'-OMe-RNA) via a disulfide bond by reacting the 3'-(pyridyldithio)-modified 2'-OMe-RNA with thiocholesterol in dichloromethane-methanol solution. This ligation reaction was made possible by a novel strategy in which the highly charged oligonucleotide was rendered soluble in nonaqueous solvent through conversion to a lipophilic amidinium salt. The biodegradable lipophilic modification of 2'-OMe-RNA resulted in a large increase in incorporation of such oligonucleotides into liposomes prepared by reversephase evaporation. Furthermore, association of these modified oligonucleotides with cultured TIB 73 cells was 100-fold higher than that seen with unmodified 2'-OMe-RNA in serum-free medium and about 10 to 30-fold higher in the presence of 10% calf serum. During incubation with cells, release of the internalized oligonucleotide from the thiocholesteryl moiety can be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741287      PMCID: PMC310419          DOI: 10.1093/nar/20.3.533

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  19 in total

1.  Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes.

Authors:  E P Feener; W C Shen; H J Ryser
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

2.  A simple procedure for the preparation of protected 2'-O-methyl or 2'-O-ethyl ribonucleoside-3'-O-phosphoramidites.

Authors:  E Wagner; B Oberhauser; A Holzner; H Brunar; G Issakides; G Schaffner; M Cotten; M Knollmüller; C R Noe
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

Review 3.  Oligonucleotide analogues as potential chemotherapeutic agents.

Authors:  G Zon
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

4.  Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells.

Authors:  A S Boutorin; L V Gus'kova; E M Ivanova; N D Kobetz; V F Zarytova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  FEBS Lett       Date:  1989-08-28       Impact factor: 4.124

5.  Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site.

Authors:  M Lemaitre; B Bayard; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

6.  2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event.

Authors:  M Cotten; B Oberhauser; H Brunar; A Holzner; G Issakides; C R Noe; G Schaffner; E Wagner; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

7.  Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

Authors:  C C Smith; L Aurelian; M P Reddy; P S Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

Authors:  C A Stein; R Pal; A L DeVico; G Hoke; S Mumbauer; O Kinstler; M G Sarngadharan; R L Letsinger
Journal:  Biochemistry       Date:  1991-03-05       Impact factor: 3.162

9.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Authors:  S Agrawal; J Goodchild; M P Civeira; A H Thornton; P S Sarin; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture.

Authors:  R L Letsinger; G R Zhang; D K Sun; T Ikeuchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

View more
  7 in total

1.  Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo.

Authors:  E A Biessen; H Vietsch; E T Rump; K Fluiter; J Kuiper; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  Synthesis and hybridization properties of oligonucleotides containing 2'-O-modified ribonucleotides.

Authors:  T H Keller; R Häner
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

Review 4.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

5.  In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide.

Authors:  N H Ing; J M Beekman; D J Kessler; M Murphy; K Jayaraman; J G Zendegui; M E Hogan; B W O'Malley; M J Tsai
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

6.  Antisense pro-drugs: 5'-ester oligodeoxynucleotides.

Authors:  N N Polushin; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

7.  Synthesis and properties of oligodeoxyribonucleotide-polyethylene glycol conjugates.

Authors:  A Jäschke; J P Fürste; E Nordhoff; F Hillenkamp; D Cech; V A Erdmann
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.